시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 HEOR(Health Economics and Outcomes Research) 서비스 시장 보고서(2025년)
Health Economics and Outcomes Research (HEOR) Services Global Market Report 2025
상품코드 : 1824388
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,457,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,334,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,211,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

HEOR(Health Economics and Outcomes Research) 서비스 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 12.1%를 나타내 27억 8,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 건강 관리 공급망 최적화, 건강 격차에 대한 관심, 가치 기반 계약 증가, 디지털 건강 및 원격 의료, 맞춤형 의료로의 전환으로 인한 것입니다. 예측 기간의 주요 동향에는 건강의 사회적 결정 요인의 법인화, 희귀질환 및 희소 의약품의 HEOR, 환자 중심의 결과 평가, 가치 프레임워크의 표준화, 신속한 실세계 근거의 창출 등이 포함됩니다.

향후 5년간의 성장률 12.1%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 에스토니아와 이스라엘에서 개발된 클라우드 기반의 건강 분석 플랫폼과 리얼 월드 에비던스 소프트웨어의 가격을 상승시켜 가치 평가 지연 및 의약품의 연구개발(R&D) 비용 상승을 초래함으로써 미국의 건강관리 의사결정을 저해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

임상시험 건수 증가가 전망되어 HEOR(Health Economics and Outcomes Research) 서비스 시장 성장을 견인하는 자세입니다. 임상시험은 새로운 치료, 개입, 진단방법의 안전성과 효능을 평가하기 위해 인간을 대상으로 한 조사연구를 포함한 것으로, 의료개입의 경제적 영향, 비용효과, 실제 결과를 평가하기 위해 HEOR 서비스를 이용합니다. 이 평가는 의사 결정과 상환 전략에 대한 귀중한 인사이트를 제공합니다. 2023년 5월 현재 미국 국립의학 도서관은 등록된 임상시험 수가 2022년 39만 9,499건에서 43만 7,533건으로 증가하여 총 50개 주와 221개국을 다뤘다고 보고했습니다. 주목할 점은 미국에서 14만 0,492시험(31%)이 등록된 반면, 24만 1,498시험(53%)이 미국 이외의 지역에서 기록되었습니다는 점입니다. 그 결과, 임상시험 증가는 HEOR(Health Economics and Outcomes Research) 서비스 시장 확대를 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Health economics and outcomes research (HEOR) services constitute a specialized domain in healthcare that employs economic and epidemiological methodologies to evaluate the clinical and financial outcomes of healthcare interventions. These services are designed to assess the cost-effectiveness, safety, and real-world impact of medical treatments, interventions, and healthcare policies.

The primary categories of health economics and outcomes research (HEOR) services encompass real-world evidence, payer evidence, pricing and reimbursement, epidemiology studies, market access, and other related services. Real-world evidence (RWE) involves the utilization of data collected from real-world settings, such as electronic health records, claims databases, and patient registries, to derive insights into the effectiveness, safety, and outcomes of treatments. These HEOR services can be either outsourced or provided in-house by service providers, including consultancies and contract research organizations (CROs), catering to a diverse range of end-users such as healthcare providers, healthcare payers, biotechnology and pharmaceutical companies, government organizations, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The health economics and outcomes research (HEOR) services market research report is one of a series of new reports from The Business Research Company that provides health economics and outcomes research (HEOR) services market statistics, including the health economics and outcomes research (HEOR) services industry's global market size, regional shares, competitors with a health economics and outcomes research (HEOR) services market share, detailed health economics and outcomes research (HEOR) services market segments, health economics and outcomes research (HEOR) services market trends and opportunities, and any further data you may need to thrive in the health economics and outcomes research (HEOR) services industry. This health economics and outcomes research (HEOR) services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The health economics and outcomes research (heor) services market size has grown rapidly in recent years. It will grow from $1.57 billion in 2024 to $1.76 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to emergence of evidence-based medicinem, healthcare policy and reforms, pharmaceutical innovations, aging population, increased chronic diseases.

The health economics and outcomes research (heor) services market size is expected to see rapid growth in the next few years. It will grow to $2.78 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to healthcare supply chain optimization, focus on health inequities, rise in value-based agreements, digital health and telemedicine, shift to personalized medicine. Major trends in the forecast period include corporation of social determinants of health, HEOR in rare diseases and orphan drugs, patient-centric outcomes assessment, value framework standardization, rapid real-world evidence generation.

The forecast of 12.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. healthcare decision-making by inflating prices of cloud-based health analytics platforms and real-world evidence software developed in Estonia and Israel, resulting in delayed value assessments and higher pharmaceutical research and development (R&D) costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expected increase in the number of clinical trials is poised to drive the growth of the market for health economics and outcomes research (HEOR) services. Clinical trials, which involve research studies with human participants to assess the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures, utilize HEOR services to evaluate the economic impact, cost-effectiveness, and real-world outcomes of medical interventions. This evaluation provides valuable insights for decision-making and reimbursement strategies. As of May 2023, the United States National Library of Medicine reported an increase in the number of registered clinical trial studies from 399,499 in 2022 to 437,533, encompassing all 50 states and 221 countries. Notably, 140,492 studies (31%) are registered in the U.S., while 241,498 studies (53%) are recorded in non-U.S. locations. Consequently, the upswing in clinical trials is fostering the expansion of the health economics and outcomes research services market.

The substantial globalization of healthcare markets is a key factor contributing to the growth of the health economics and outcomes research (HEOR) services market. This globalization necessitates the adaptation of HEOR services to diverse healthcare systems. According to a report by the United Nations Conference on Trade and Development, the healthcare and medication sectors are rapidly globalizing, and medical education is also becoming more globalized with continued migration for undergraduate and graduate medical education. Therefore, the globalization of healthcare markets is expected to propel the health economics and outcomes research (HEOR) services market forward.

Advancements in real-world evidence platforms are emerging as a prominent trend in the health economics and outcomes research (HEOR) services market. Major companies in this market are embracing innovative technologies to revolutionize healthcare decision-making, drug development, and patient care. By leveraging real-world data, these companies aim to generate evidence-based insights. One example is Komodo Health, a U.S.-based healthcare technology company specializing in real-world evidence and data analytics. In April 2023, Komodo Health launched MapEnhance, an integrated network of specialty data partners within its real-world evidence technology platform. This platform enhances the analytical capabilities of Komodo's Healthcare Map by incorporating exclusive and highly informative data from its partner network. MapEnhance provides customers with a comprehensive and detailed real-world perspective on clinical events and patient populations, offering unprecedented insights.

Major players in the health economics and outcomes research (HEOR) services market are also concentrating on developing services specifically tailored for digital therapeutics providers. Companies are expanding the application of HEOR services to broader sectors, such as digital therapeutics, to provide vendors with enhanced market analysis. For instance, Curavit, a U.S.-based research organization, launched Health Economics and Outcomes Research (HEOR) for digital therapeutic trials in November 2023. These services focus on evaluating the health economics value of digital therapeutics, both at the individual patient and population levels of care. HEOR will be incorporated into clinical trials to quantify the financial impact of digital therapeutics and will be analyzed at the study's close-out.

In January 2023, SCIRIS, a UK-based company specializing in healthcare communications and compliance solutions, acquired Source Health Economics for an undisclosed amount. This acquisition enhances SCIRIS's capabilities in providing comprehensive health economics and outcomes research (HEOR) services to global clients, enabling success across all stages of brand development. Source Health Economics, a UK-based HEOR consulting company, is engaged in health technology assessment, statistics, health economics, and medical writing.

Major companies operating in the health economics and outcomes research (HEOR) services market include McKesson Corporation, Optum Inc., Cardinal Health, IQVIA Inc., ICON PLC, PPD Inc., Syneos Health, Medlior Health Outcomes Research Ltd., Axtria Inc., Parexel International, RTI Health Solutions, Wellth Inc., Westat, SidekickHealth, Analysis Group, Carelon Research, Precision Health Economics, Avalon Health Economics LLC, Lumanity Inc., Pharmerit BV, Epistemix Inc., Bohn Epidemiology LLC

North America was the largest region in the health economics and outcomes research (HEOR) services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the health economics and outcomes research (heor) services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the health economics and outcomes research (heor) services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The health economics and outcomes research (HEOR) services market includes revenues earned by entities by providing economic modeling, health outcomes assessment, and comparative effectiveness research services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Health Economics and Outcomes Research (HEOR) Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on health economics and outcomes research (heor) services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for health economics and outcomes research (heor) services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The health economics and outcomes research (heor) services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Health Economics and Outcomes Research (HEOR) Services Market Characteristics

3. Health Economics and Outcomes Research (HEOR) Services Market Trends And Strategies

4. Health Economics and Outcomes Research (HEOR) Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Health Economics and Outcomes Research (HEOR) Services Growth Analysis And Strategic Analysis Framework

6. Health Economics and Outcomes Research (HEOR) Services Market Segmentation

7. Health Economics and Outcomes Research (HEOR) Services Market Regional And Country Analysis

8. Asia-Pacific Health Economics and Outcomes Research (HEOR) Services Market

9. China Health Economics and Outcomes Research (HEOR) Services Market

10. India Health Economics and Outcomes Research (HEOR) Services Market

11. Japan Health Economics and Outcomes Research (HEOR) Services Market

12. Australia Health Economics and Outcomes Research (HEOR) Services Market

13. Indonesia Health Economics and Outcomes Research (HEOR) Services Market

14. South Korea Health Economics and Outcomes Research (HEOR) Services Market

15. Western Europe Health Economics and Outcomes Research (HEOR) Services Market

16. UK Health Economics and Outcomes Research (HEOR) Services Market

17. Germany Health Economics and Outcomes Research (HEOR) Services Market

18. France Health Economics and Outcomes Research (HEOR) Services Market

19. Italy Health Economics and Outcomes Research (HEOR) Services Market

20. Spain Health Economics and Outcomes Research (HEOR) Services Market

21. Eastern Europe Health Economics and Outcomes Research (HEOR) Services Market

22. Russia Health Economics and Outcomes Research (HEOR) Services Market

23. North America Health Economics and Outcomes Research (HEOR) Services Market

24. USA Health Economics and Outcomes Research (HEOR) Services Market

25. Canada Health Economics and Outcomes Research (HEOR) Services Market

26. South America Health Economics and Outcomes Research (HEOR) Services Market

27. Brazil Health Economics and Outcomes Research (HEOR) Services Market

28. Middle East Health Economics and Outcomes Research (HEOR) Services Market

29. Africa Health Economics and Outcomes Research (HEOR) Services Market

30. Health Economics and Outcomes Research (HEOR) Services Market Competitive Landscape And Company Profiles

31. Health Economics and Outcomes Research (HEOR) Services Market Other Major And Innovative Companies

32. Global Health Economics and Outcomes Research (HEOR) Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Health Economics and Outcomes Research (HEOR) Services Market

34. Recent Developments In The Health Economics and Outcomes Research (HEOR) Services Market

35. Health Economics and Outcomes Research (HEOR) Services Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기